Pioneering vaccine strategy promises to outmaneuver antimicrobial resistance

FHS
April 8, 2024
3:54 am

Study introduces Reverse Vaccine Development as a strategic approach to identify correlates of protection early in vaccine development against antimicrobial-resistant pathogens, aiming to mitigate risks such as significant phase-III clinical trial failures.

House panel eyes PBM reform to pay for telehealth extensions

A new bill set to be considered on Wednesday by the House Ways & Means Committee would extend for two years telehealth flexibilities for Medicare

May 7, 2024

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023 – Biotech Investments

Rancho Cucamonga, 08/08/2023 / 13:06, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. Reports Net Revenues of $145.7 Million for the Three Months Ended June

August 9, 2023

With Covid revenues falling, Pfizer lays out growth plans and possible cost cuts

As the Pfizer behemoth continues chugging along post-pandemic, the drugmaker is starting to clarify how its Covid-19 profits will turn into future growth. For the

August 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.